A M E Walenkamp - JoVE Visualize

Showing results (1-10 of 13) with videos related to

Pageof 2

Sort By:

Critical Reviews in Oncology/Hematology|December 10, 2016

Cancer treatment induced metabolic syndrome: Improving outcome with lifestyleN L Westerink, J Nuver, J D Lefrandt, et al.

Current Opinion in Pharmacology|July 16, 2008

Targeting TRAIL death receptorsC N A M Oldenhuis, J H Stegehuis, A M E Walenkamp, et al.

Psycho-Oncology|December 17, 2017

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic reviewH L Ormel, G G F van der Schoot, W J Sluiter, et al.

Pediatric Blood & Cancer|October 29, 2010

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemiaR C Kruizinga, H J M de Jonge, K R Kampen, et al.

Critical Reviews in Oncology/Hematology|August 17, 2010

The chemokine network, a newly discovered target in high grade gliomasU M Domanska, R C Kruizinga, W F A den Dunnen, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO frameworkL D de Hosson, L M van Veenendaal, Y Schuller, et al.

Orphanet Journal of Rare Diseases|March 2, 2019

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trialL D de Hosson, G Bouma, J Stelwagen, et al.

British Journal of Cancer|February 13, 2014

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activityM J M Gooden, V R Wiersma, A Boerma, et al.

Alimentary Pharmacology & Therapeutics|November 6, 2010

Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogueH-B Fiebrich, G Van Den Berg, I P Kema, et al.

Cell Death & Disease|October 3, 2014

TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasionJ V Joseph, S Conroy, T Tomar, et al.

Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:

Pageof 2

Critical Reviews in Oncology/Hematology|December 10, 2016

Cancer treatment induced metabolic syndrome: Improving outcome with lifestyleN L Westerink, J Nuver, J D Lefrandt, et al.

Current Opinion in Pharmacology|July 16, 2008

Targeting TRAIL death receptorsC N A M Oldenhuis, J H Stegehuis, A M E Walenkamp, et al.

Psycho-Oncology|December 17, 2017

Predictors of adherence to exercise interventions during and after cancer treatment: A systematic reviewH L Ormel, G G F van der Schoot, W J Sluiter, et al.

Pediatric Blood & Cancer|October 29, 2010

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemiaR C Kruizinga, H J M de Jonge, K R Kampen, et al.

Critical Reviews in Oncology/Hematology|August 17, 2010

The chemokine network, a newly discovered target in high grade gliomasU M Domanska, R C Kruizinga, W F A den Dunnen, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO frameworkL D de Hosson, L M van Veenendaal, Y Schuller, et al.

Orphanet Journal of Rare Diseases|March 2, 2019

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trialL D de Hosson, G Bouma, J Stelwagen, et al.

British Journal of Cancer|February 13, 2014

Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activityM J M Gooden, V R Wiersma, A Boerma, et al.

Alimentary Pharmacology & Therapeutics|November 6, 2010

Deficiencies in fat-soluble vitamins in long-term users of somatostatin analogueH-B Fiebrich, G Van Den Berg, I P Kema, et al.

Cell Death & Disease|October 3, 2014

TGF-β is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasionJ V Joseph, S Conroy, T Tomar, et al.

Pageof 2